2.Retroviral-mediated IL-12 gene therapy for advanced murine tumors.
Seon Hee KIM ; Chung Sun AN ; Hideaki TAHARA ; Chae Hwa PARK ; Michael T LOTZE ; Paul D ROBBINS ; Sun Young KIM
Experimental & Molecular Medicine 1997;29(1):53-58
Interleukin 12 (IL-12), a heterodimeric cytokine, promotes an effective antitumor response against tumors of various histological types when delivered systemically as a protein or locally by gene transfer. We investigated parameters that influenced the effectiveness of IL-12 retroviral-mediated gene therapy of cancer in animals using the murine breast cancer line TS/A. Syngeneic fibroblasts (TIB80), stably transduced with a retrovirus expressing murine IL-12, were used for peritumoral injection. Injection of fibroblasts into established tumors resulted in complete regression of tumor in 40 % of animals in a dose dependent manner when treated on day 4, and 20 % when treated on day 8. Significant inhibition of growth of day 21 and day 40 tumors was observed following peritumoral injection of IL-12-expressing fibroblasts in a dose-dependent manner. Delivery of IL-12 by syngeneic fibroblasts at a tumor site is effective in eradicating established, weakly immunogenic TS/A tumors.
Animals
;
Breast Neoplasms
;
Fibroblasts
;
Genetic Therapy*
;
Interleukin-12*
;
Retroviridae